our services
We employ latest research technology & company.
Our expertise for your success
Our mission, our excellent science and our strong sense of purpose guide us in all we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe.
By continuing to grow in response to our clients’ needs, we can now offer the most comprehensive, integrated portfolio of drug development products and services available from a single global provider, spanning the continuum from early research to the support of marketed products. Whether we are helping to chart the course from bench to clinic or working to achieve a particular study milestone, we are proud to partner with our clients on their journey of bringing new therapies to market.
By continuing to grow in response to our clients’ needs, we can now offer the most comprehensive, integrated portfolio of drug development products and services available from a single global provider, spanning the continuum from early research to the support of marketed products. Whether we are helping to chart the course from bench to clinic or working to achieve a particular study milestone, we are proud to partner with our clients on their journey of bringing new therapies to market.
medical diagnostic
High-quality inbred, outbred, disease, germ free, and immunodeficient model
safety assessment
High-quality inbred, outbred, disease, germ-free, and immunodeficient model
Qc microbial testing solutions
High-quality inbred, outbred, disease, germ free, and immunodeficient model
Laboratory science
High-quality inbred, outbred, disease, germ-free, and immunodeficient model
Screening & Profiling Assays
High-quality inbred, outbred, disease, germ-free, and immunodeficient model
Formulation & Product Chemistry
High-quality inbred, outbred, disease, germ-free, and immunodeficient model
Biologics Testing Solutions
High-quality inbred, outbred, disease, germ-free, and immunodeficient model
Research Models & Services
High-quality inbred, outbred, disease, germ-free, and immunodeficient model
Related insights
Are You Prepared for Future Challenges?
In pediatrics, young patients may not be able to communicate the exact location and intensity of the pain they’re experiencing. With SPECT/CT the origin of pain becomes clearly visible, which can lead to more accurate diagnoses and surgical planning. Nuclear medicine physicians are learning how to share visual findings from SPECT/CT with referring orthopedic surgeons, resulting in improved collaboration and outcomes.
Can My Research Continue?
One of the leading companies in the sector warns that they tend to give false negatives in people with lower amounts of virus and point out that they are only reliable in those with high viral load
The convergence of nuclear medicine
In pediatrics, young patients may not be able to communicate the exact location and intensity of the pain they’re experiencing. With SPECT/CT the origin of pain becomes clearly visible, which can lead to more accurate diagnoses and surgical planning. Nuclear medicine physicians are learning how to share visual findings from SPECT/CT with referring orthopedic surgeons, resulting in improved collaboration and outcomes.
New antigen tests are worse than PCR for evaluating asymptomatic patients in the future
One of the leading companies in the sector warns that they tend to give false negatives in people with lower amounts of virus and point out that they are only reliable in those with high viral load...
The Guidelines and Challenges of Performing NHP DART Studies
At its annual Quantum Summit in New York, IBM unveiled its quantum roadmap for both hardware and software through the next 10 years. It represents a continuation of the roadmaps they have presented but also promises a disruptive leap for 2024.